---
title: "Mabpharm Limited Updates Nomination Committee Terms"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/263724867.md"
description: "Mabpharm Limited (HK:2181) has updated the terms of reference for its Nomination Committee, which will now review the board’s structure, assess director independence, support performance evaluations, and oversee succession planning. The latest analyst rating for Mabpharm's stock is a Hold with a price target of HK$0.50. The company, incorporated in the Cayman Islands, has a market cap of HK$2.35B and an average trading volume of 701,064 shares."
datetime: "2025-10-31T11:11:29.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263724867.md)
  - [en](https://longbridge.com/en/news/263724867.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263724867.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/263724867.md) | [繁體中文](https://longbridge.com/zh-HK/news/263724867.md)


# Mabpharm Limited Updates Nomination Committee Terms

Mabpharm Limited ( (HK:2181) ) just unveiled an announcement.

Mabpharm Limited has amended the terms of reference for its Nomination Committee, which is responsible for reviewing the board’s structure, size, and composition, and making recommendations for changes to align with corporate strategy. The committee will also assess the independence of directors, support board performance evaluations, and oversee succession planning for key roles, ensuring the company’s leadership remains effective and compliant with employment terms.

The most recent analyst rating on (HK:2181) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Mabpharm Limited stock, see the HK:2181 Stock Forecast page.

**More about Mabpharm Limited**

Mabpharm Limited is a company incorporated in the Cayman Islands, operating with limited liability. It is listed under the stock code 2181.

**Average Trading Volume:** 701,064

**Technical Sentiment Signal:** Buy

**Current Market Cap:** HK$2.35B

### Related Stocks

- [MABPHARM-B (02181.HK)](https://longbridge.com/en/quote/02181.HK.md)

## Related News & Research

- ['Drowned Punjab in corruption, drugs and crime': Amit Shah hits at AAP govt](https://longbridge.com/en/news/279114423.md)
- [Paris mayoral race tests support for green transformation](https://longbridge.com/en/news/279040642.md)
- [Paralympics-Broken kit, no problem: the Paralympics rapid‑repair lifeline](https://longbridge.com/en/news/279096386.md)
- [Assessing Wallenstam (OM:WALL B) Valuation After Recent Gothenburg And Stockholm Property Moves](https://longbridge.com/en/news/279060431.md)
- [Assessing Skanska (OM:SKA B) Valuation After New US Data Center And Los Angeles Infrastructure Contracts](https://longbridge.com/en/news/278926011.md)